SCGB3A1 and nasopharyngeal carcinoma: Recent reports showed that HIN-1 expression is downregulated in the majority of lung, breast, prostate, pancreatic, colorectal, testicular, and nasopharyngeal cancers, and this downregulation is associated with hypermethylation of the HIN-1 promoter[27-30].